Novantrone

Active Ingredient(s): Mitoxantrone
FDA Approved: * December 23, 1987
Pharm Company: * SERONO INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Novantrone Overview

Mitoxantrone (INN, BAN, USAN; also known as Mitozantrone in Australia; trade name Novantrone) is an anthracenedione antineoplastic agent. Contents 1 Uses 2 Side effects 3 Mechanism of action 4 See also 5 References Uses Mitoxantrone is used in the treatment of certain types of cancer, mostly metastatic breast cancer, acute myeloid leukemia, and non-Hodgkin's lymphoma. It was also shown to improve the survival rate of children suffering from first relapse of acute lymphoblastic leu...

Read more Novantrone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mitoxantrone

Recent Novantrone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Mitoxantrone
  • Injection: 20mg/10ml (2mg/ml), 20mg/10ml(2mg/ml), 25mg/12.5ml (2mg/ml), 2mg/ml, 30mg/15ml (2mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Mitoxantrone or a similar ingredient: (1 result)